Lot 2026.09 · Point-in-time since 2001
Sourcebrook links listed drug companies to the plants that make their drugs, and to every inspection problem there.
01 / Traceability
We read which plant makes each drug from annual reports and FDA drug labels, then attach everything on record there: FDA inspections, warning letters and what companies disclosed.
From SEC EDGAR.
From the FDA drug label.
The label: “Manufactured by (188 mg vials): Catalent Indiana, LLC”.
The plant is also named in 8-Ks by Regeneron, Scholar Rock and Incyte.
FEI 3005949964 · 1300 S Patterson Dr, Bloomington, Indiana
02 / The gap
FDA's public dashboard lists final classifications only and leaves out pre-approval inspections. Companies often disclose the problem first, in their own filings.
Bausch Health Companies Inc. BHC · CIK 0000885590
“In June 2026, following a routine FDA inspection of our B+L Tampa, Florida facility, as part of its findings, the FDA issued an Official Action Indicated (“OAI”) of B+L’s Tampa, Florida facility.”
plant problems we matched in company filings since 2009 never reached FDA's dashboard.
of the problems tied to a drug under FDA review never reached it either.
03 / Specification
What a license contains, counted from the sources, and how often our labels were right when checked by hand.
Plant Inspection Records
| Test | Specification | Result | Status |
|---|---|---|---|
| Companies | US-listed drug and biologics filers | 655 | Complies |
| Company–plant links | Plants named in 10-Ks and FDA drug labels | 210 companies | Complies |
| FDA facilities | Drug and biologics sites, FDA Data Dashboard | 26,911 | Complies |
| FDA inspections | Classified NAI, VAI or OAI, Oct 2008 onward | 66,781 | Complies |
| Filings read | 8-K, 10-Q, 10-K and 6-K, 2001 onward | 8,055 | Complies |
| Disclosed statements | Quoted, time-stamped to SEC acceptance | 1,677 | Complies |
| EU and UK statements | GMP non-compliance, EudraGMDP and MHRA | 87 | Complies |
| Label precision | Kept statements that were real inspection problems, checked by hand | 92–95 % 2019–26 80 % 2001–18 | Complies |
| Personal data | None | None | Complies |
| Non-public information | None | None | Complies |
Sources: SEC EDGAR, FDA Data Dashboard, openFDA, FDA warning letters, EudraGMDP, MHRA. Every record was public when dated. Plant IDs are mapped with today's FDA plant list.
Many companies don't name their manufacturers. Where a filing names a manufacturer but not the site, every candidate site is listed and marked.
04 / Delivery
CSV tables with a data dictionary. Each row carries the moment it became public, so the history replays as it was known.
Company disclosures back to 2001 and FDA inspections back to October 2008, in one file set.
New and changed rows every week, with the same columns and identifiers: ticker, SEC CIK, FDA FEI.
OAI classifications, warning letters and company disclosures, on the day they appear.
What it isn't
Public records only No personal data No non-public information No predictions or ratings Not investment adviceTell us which companies or plants you follow. We'll check coverage for them first.
